568 related articles for article (PubMed ID: 16230678)
1. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
Lanciano R; Calkins A; Bundy BN; Parham G; Lucci JA; Moore DH; Monk BJ; O'Connor DM
J Clin Oncol; 2005 Nov; 23(33):8289-95. PubMed ID: 16230678
[TBL] [Abstract][Full Text] [Related]
2. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group.
Stehman FB; Bundy BN; Kucera PR; Deppe G; Reddy S; O'Connor DM
Gynecol Oncol; 1997 Aug; 66(2):262-7. PubMed ID: 9264574
[TBL] [Abstract][Full Text] [Related]
4. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
[TBL] [Abstract][Full Text] [Related]
5. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer.
Thomas G; Dembo A; Ackerman I; Franssen E; Balogh J; Fyles A; Levin W
Gynecol Oncol; 1998 May; 69(2):137-45. PubMed ID: 9600821
[TBL] [Abstract][Full Text] [Related]
7. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
[TBL] [Abstract][Full Text] [Related]
8. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
[TBL] [Abstract][Full Text] [Related]
9. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
[TBL] [Abstract][Full Text] [Related]
10. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
Smalley SR; Benedetti JK; Williamson SK; Robertson JM; Estes NC; Maher T; Fisher B; Rich TA; Martenson JA; Kugler JW; Benson AB; Haller DG; Mayer RJ; Atkins JN; Cripps C; Pedersen J; Periman PO; Tanaka MS; Leichman CG; Macdonald JS
J Clin Oncol; 2006 Aug; 24(22):3542-7. PubMed ID: 16877719
[TBL] [Abstract][Full Text] [Related]
11. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications.
Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1370-7. PubMed ID: 16979836
[TBL] [Abstract][Full Text] [Related]
12. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment.
Torres MA; Jhingran A; Thames HD; Levenback CF; Bodurka DC; Ramondetta LM; Eifel PJ
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):118-25. PubMed ID: 17869451
[TBL] [Abstract][Full Text] [Related]
13. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Rose PG; Bundy BN; Watkins EB; Thigpen JT; Deppe G; Maiman MA; Clarke-Pearson DL; Insalaco S
N Engl J Med; 1999 Apr; 340(15):1144-53. PubMed ID: 10202165
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer: combined modality therapy.
Grigsby PW
Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
[TBL] [Abstract][Full Text] [Related]
15. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
[TBL] [Abstract][Full Text] [Related]
16. Combined-modality therapy of locally advanced cervical cancer.
Rose PG
J Clin Oncol; 2003 May; 21(10 Suppl):211s-217s. PubMed ID: 12743137
[TBL] [Abstract][Full Text] [Related]
17. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
Serkies K; Jassem J
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
[TBL] [Abstract][Full Text] [Related]
19. Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
Sakata K; Sakurai H; Suzuki Y; Katoh S; Ohno T; Toita T; Kataoka M; Tanaka E; Kaneyasu Y; Uno T; Harima Y; Nakano T;
Acta Oncol; 2008; 47(3):434-41. PubMed ID: 18348003
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
Rose PG; Ali S; Watkins E; Thigpen JT; Deppe G; Clarke-Pearson DL; Insalaco S;
J Clin Oncol; 2007 Jul; 25(19):2804-10. PubMed ID: 17502627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
